22 May 2013
Keywords: eu, majors, agree, serd, deal, anglo-swedish, drug
Article | 25 September 2006
Anglo-Swedish drug major AstraZeneca and Germany's Schering AG say they have agreed to jointly develop and commercialize a selective estrogen
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 September 2006
21 May 2013
© 2013 thepharmaletter.com